Skip to main content
Article
Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in FCS in mice and humans
Journal of Immunology (2007)
  • Norihisa Sakamoto, Food and Drug Administration
  • Kuzuhide Tuji
  • Linda M Muul, National Institutes of Health
  • Ann M Lawler
  • Fabio Candotti, National Institutes of Health
  • Julia A Metcalf, National Institutes of Health
  • Jorge A Tavel, National Institutes of Health
  • H.Clifford Lane, National Institutes of Health
  • Walter J Urba, Providence Portland Medical Center
  • Bernard A Fox, Providence Portland Medical Center
  • Ajit P Varki, University of California, Berkeley
  • Joan K Lunney, United States Department of Agriculture
  • Amy S Rosenberg, Food and Drug Administration
Publication Date
April 1, 2007
Citation Information
Norihisa Sakamoto, Kuzuhide Tuji, Linda M Muul, Ann M Lawler, et al.. "Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in FCS in mice and humans" Journal of Immunology Vol. 178 (2007)
Available at: http://works.bepress.com/walter-urba/186/